MedTrace Logo

Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer

NCT05773144 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 219

Last updated 2026-01-07

No results posted yet for this study

Summary

To goal of this clinical trial is to quantify the dose-response effects of aerobic exercise training compared to attention control on chemotherapy relative dose intensity in colon cancer survivors.

Conditions

  • Colonic Neoplasms

Interventions

BEHAVIORAL

Aerobic exercise

Moderate- to vigorous-intensity aerobic exercise

BEHAVIORAL

Progressive stretching

Static stretching of eight major muscle groups

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • AdventHealth Translational Research Institute

    lead OTHER

Principal Investigators

  • Justin C. Brown, Ph.D. · AdventHealth

  • Jeffrey A. Meyerhardt, M.D., M.P.H. · Dana-Farber Cancer Institute

  • Bette J. Caan, Dr.P.H. · Kaiser Permanente

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2027-05-01
Completion
2027-05-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05773144 on ClinicalTrials.gov